116 related articles for article (PubMed ID: 11849458)
1. Association of the tissue kallikrein gene promoter with ESRD and hypertension.
Yu H; Song Q; Freedman BI; Chao J; Chao L; Rich SS; Bowden DW
Kidney Int; 2002 Mar; 61(3):1030-9. PubMed ID: 11849458
[TBL] [Abstract][Full Text] [Related]
2. Significance of the tissue kallikrein promoter and transforming growth factor-beta1 polymorphisms with renal progression in children with vesicoureteral reflux.
Lee-Chen GJ; Liu KP; Lai YC; Juang HS; Huang SY; Lin CY
Kidney Int; 2004 Apr; 65(4):1467-72. PubMed ID: 15086490
[TBL] [Abstract][Full Text] [Related]
3. Genomic structure of the human plasma prekallikrein gene, identification of allelic variants, and analysis in end-stage renal disease.
Yu H; Anderson PJ; Freedman BI; Rich SS; Bowden DW
Genomics; 2000 Oct; 69(2):225-34. PubMed ID: 11031105
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of genetic variation and association in the matrix metalloproteinase 9 (MMP9) gene in ESRD patients.
Hirakawa S; Lange EM; Colicigno CJ; Freedman BI; Rich SS; Bowden DW
Am J Kidney Dis; 2003 Jul; 42(1):133-42. PubMed ID: 12830465
[TBL] [Abstract][Full Text] [Related]
5. Association of functional kallikrein-1 promoter polymorphisms and acute kidney injury: a case-control and longitudinal cohort study.
Susantitaphong P; Perianayagam MC; Kang SW; Zhang W; Rao F; O'Connor DT; Jaber BL
Nephron Clin Pract; 2012; 122(3-4):107-13. PubMed ID: 23635481
[TBL] [Abstract][Full Text] [Related]
6. Identification of human plasma kallikrein gene polymorphisms and evaluation of their role in end-stage renal disease.
Yu H; Bowden DW; Spray BJ; Rich SS; Freedman BI
Hypertension; 1998 Apr; 31(4):906-11. PubMed ID: 9535413
[TBL] [Abstract][Full Text] [Related]
7. Association of an IL-1A 3'UTR polymorphism with end-stage renal disease and IL-1 alpha expression.
Bensen JT; Langefeld CD; Li L; McCall CE; Cousart SL; Dryman BN; Freedman BI; Bowden DW
Kidney Int; 2003 Apr; 63(4):1211-9. PubMed ID: 12631337
[TBL] [Abstract][Full Text] [Related]
8. A coding polymorphism of the kallikrein 1 gene is associated with essential hypertension: a tagging SNP-based association study in a Chinese Han population.
Zhao W; Wang L; Lu X; Yang W; Huang J; Chen S; Gu D
J Hypertens; 2007 Sep; 25(9):1821-7. PubMed ID: 17762646
[TBL] [Abstract][Full Text] [Related]
9. Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study.
Timmermann B; Mo R; Luft FC; Gerdts E; Busjahn A; Omvik P; Li GH; Schuster H; Wienker TF; Hoehe MR; Lund-Johansen P
Kidney Int; 1998 Jun; 53(6):1455-60. PubMed ID: 9607174
[TBL] [Abstract][Full Text] [Related]
10. Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans.
Freedman BI; Yu H; Spray BJ; Rich SS; Rothschild CB; Bowden DW
Kidney Int; 1997 Mar; 51(3):819-25. PubMed ID: 9067916
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of nitric oxide and endothelin in end-stage renal disease.
Freedman BI; Yu H; Anderson PJ; Roh BH; Rich SS; Bowden DW
Nephrol Dial Transplant; 2000 Nov; 15(11):1794-800. PubMed ID: 11071967
[TBL] [Abstract][Full Text] [Related]
12. HLA-G gene expression influenced at allelic level in association with end stage renal disease and acute allograft rejection.
Misra MK; Pandey SK; Kapoor R; Sharma RK; Kapoor R; Prakash S; Agrawal S
Hum Immunol; 2014 Aug; 75(8):833-9. PubMed ID: 24929145
[TBL] [Abstract][Full Text] [Related]
13. [The relationship between the variants in 5' upstream core promoter A(-6)G and A(-20)C of angiotensinogen gene and essential hypertension in Kazakans of Xinjiang].
Li NF; Zhou L; Wu WD; Shi Y; Wang XL; Wang J; Li HJ; Zhang DL; Zu H; Ouyang WJ; Bu KL; Zhou KM; Cheng QY; Guli N; Zhu DH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):23-8. PubMed ID: 14767903
[TBL] [Abstract][Full Text] [Related]
14. DNA polymorphisms in the 5'-flanking region of the human tissue kallikrein gene.
Song Q; Chao J; Chao L
Hum Genet; 1997 Jun; 99(6):727-34. PubMed ID: 9187664
[TBL] [Abstract][Full Text] [Related]
15. Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy.
Maeda S; Haneda M; Guo B; Koya D; Hayashi K; Sugimoto T; Isshiki K; Yasuda H; Kashiwagi A; Kikkawa R
Kidney Int; 2001 Oct; 60(4):1428-34. PubMed ID: 11576356
[TBL] [Abstract][Full Text] [Related]
16. A single nucleotide polymorphism in the UMOD promoter is associated with end stage renal disease.
Chen T; Wang Q; Li G; Wang L
BMC Med Genet; 2016 Dec; 17(1):95. PubMed ID: 27938332
[TBL] [Abstract][Full Text] [Related]
17. Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease.
Misra MK; Prakash S; Kapoor R; Pandey SK; Sharma RK; Agrawal S
Tissue Antigens; 2013 Nov; 82(5):317-26. PubMed ID: 24131018
[TBL] [Abstract][Full Text] [Related]
18. Correlation between a gene polymorphism of tumor necrosis factor-alpha (G/A) and end-stage renal disease: a pilot study from north India.
Manchanda PK; Kumar A; Kaul A; Mittal RD
Clin Chim Acta; 2006 Aug; 370(1-2):152-7. PubMed ID: 16545788
[TBL] [Abstract][Full Text] [Related]
19. A positive association between the human tissue kallikerin gene A2233C polymorphism and blood pressure response to benazepril.
Hong Z; Pan L; Fei J; Ma Z; Hong Z
Clin Exp Hypertens; 2017; 39(5):389-393. PubMed ID: 28621557
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism of the renalase gene in end-stage renal disease patients affected by hypertension.
Stec A; Semczuk A; Furmaga J; Ksiazek A; Buraczynska M
Nephrol Dial Transplant; 2012 Nov; 27(11):4162-6. PubMed ID: 21617193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
